Key facts
- It has raised $710K; the latest was Seed Round ($560K) in Apr 2025.
- Notable investors include Creative Destruction Lab, SOSV, University of Toronto, Hustle Fund, IndieBio — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Materia Bioworks
- ·The full record, as it builds
Funding rounds
No funding rounds for Materia Bioworks are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Materia Bioworks
Developer of data-driven informatics tools designed to launch sustainable products with biomaterials. The company's tools offer artificial intelligence-powered formulation to streamline the entire process from material sourcing to product manufacturing, enabling material scientists, product developers, suppliers, and converters to improve and accelerate their development of biomaterial applications.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2023
- Employees
- 9
- Website
- materiabioworks.com/
- Ownership
- Privately Held (backing)
Materia Bioworks doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Materia Bioworks shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Materia Bioworks in its N-PORT filings yet. We sweep new filings monthly.